Catalyst Wire Dossier Catalyst Wire Dossier

INTERCEPT Blood System for Red Blood Cells with AS-1

· Cerus Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INTERCEPT Blood System for Red Blood Cells with AS-1, covering 2025-10-15 to 2025-10-15. Get the full timeline:

Most recent: Clinical Trial Update: A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1 [Phase 2]

See pricing